TRANSCEPT PHARMACEUTICALS

transcept-pharmaceuticals-logo

Transcept Pharmaceuticals, Inc. uses its proprietary delivery system to enhance the penetration of drugs, significantly speeding their onset of action. Transcept is developing rapid-acting versions of several major market pharmaceuticals. Hamilton co-invested in the company's first institutional round of funding alongside Montreaux Equity Partners, Peninsula Equity Partners and Vivo Ventures. Investors in subsequent financing rounds include these firms, and New Leaf Venture Partners, Interwest Partners and New Enterprise Associates.

#People #Financial #Website #More

TRANSCEPT PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Neuroscience Pharmaceutical Therapeutics

Founded:
2001-01-01

Address:
Richmond, California, United States

Country:
United States

Website Url:
http://www.transoral.com

Total Employee:
11+

Status:
Closed

Contact:
(510) 215-3500

Email Addresses:
[email protected]

Total Funding:
40 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema



Current Advisors List

jake-nunn_image

Jake Nunn Board of Directors @ Transcept Pharmaceuticals
Board_member

Founder


nikhilesh-singh_image

Nikhilesh Singh

tom-soloway_image

Tom Soloway

Stock Details


Company's stock symbol is NASDAQ:TSPT

Acquisitions List

Date Company Article Price
2009-02-02 Novacea Novacea acquired by Transcept Pharmaceuticals N/A

Investors List

herculescapital_image

Hercules Capital

Hercules Capital investment in Series D - Transcept Pharmaceuticals

peninsula-equity-partners_image

Peninsula Ventures

Peninsula Ventures investment in Series D - Transcept Pharmaceuticals

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series D - Transcept Pharmaceuticals

vivo-capital_image

Vivo Capital

Vivo Capital investment in Series D - Transcept Pharmaceuticals

hamilton-bioventures_image

Hamilton BioVentures

Hamilton BioVentures investment in Series D - Transcept Pharmaceuticals

montreaux-equity-partners_image

Montreux Equity Partners

Montreux Equity Partners investment in Series D - Transcept Pharmaceuticals

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series D - Transcept Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series D - Transcept Pharmaceuticals

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series A - Transcept Pharmaceuticals

Official Site Inspections

http://www.transoral.com

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 13.248.169.48
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Transcept Pharmaceuticals" on Search Engine